Division of General and Visceral Surgery, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
Division of Experimental Allergy and Immunodermatology, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
Front Immunol. 2022 May 11;13:837097. doi: 10.3389/fimmu.2022.837097. eCollection 2022.
Recently, the V-domain immunoglobulin suppressor of T-cell activation (VISTA) was identified as a negative immune checkpoint regulator (NCR) that is mainly expressed in hematopoietic cells. Preclinical studies have shown that VISTA blockade results in impeded tumor growth and improved survival. Nevertheless, little is known about the physiological role of VISTA expression in macrophages. This study focused on the differential expression of VISTA in human monocytes and macrophages in order to elucidate a putative role of VISTA regulation upon macrophage polarization and activation. We observed that human peripheral monocytes constitutively release soluble VISTA, which was regulated matrix metalloproteinases. However, monocyte stimulation with cytokines that induce macrophage differentiation, such as granulocyte-macrophage colony-stimulating (GM-CSF) and macrophage colony-stimulating factor (M-CSF), substantially reduced soluble VISTA release. VISTA release was further affected by various pro- and anti-inflammatory stimuli that led to macrophage polarization, where activated M1 macrophages generally released more VISTA than M2 macrophages. Additionally, we observed that stimulation of activated macrophages with the toll-like receptor 4 ligand lipopolysaccharide (LPS) led to a further decrease of soluble VISTA release. Moreover, we found that soluble VISTA impairs T cell cytotoxic activity but did not induce their programmed death. Our results suggest that VISTA is constantly produced and released in the peripheral blood where it may contribute to peripheral tolerance.
最近,T 细胞活化的 V 域免疫球蛋白抑制因子(VISTA)被鉴定为一种主要在造血细胞中表达的负免疫检查点调节剂(NCR)。临床前研究表明,阻断 VISTA 可抑制肿瘤生长并提高生存率。然而,关于 VISTA 在巨噬细胞中的生理作用知之甚少。本研究专注于 VISTA 在人单核细胞和巨噬细胞中的差异表达,以阐明 VISTA 调节在巨噬细胞极化和激活中的潜在作用。我们观察到,人外周单核细胞持续释放可溶性 VISTA,其受到基质金属蛋白酶的调节。然而,用诱导巨噬细胞分化的细胞因子(如粒细胞-巨噬细胞集落刺激因子(GM-CSF)和巨噬细胞集落刺激因子(M-CSF))刺激单核细胞会显著减少可溶性 VISTA 的释放。可溶性 VISTA 的释放还受到各种促炎和抗炎刺激的影响,这些刺激导致巨噬细胞极化,其中活化的 M1 巨噬细胞通常比 M2 巨噬细胞释放更多的 VISTA。此外,我们观察到用 Toll 样受体 4 配体脂多糖(LPS)刺激活化的巨噬细胞会进一步降低可溶性 VISTA 的释放。此外,我们发现可溶性 VISTA 会损害 T 细胞的细胞毒性活性,但不会诱导其程序性死亡。我们的研究结果表明,VISTA 不断在周围血液中产生和释放,可能有助于外周耐受。